CN115884766A - 用于使用中链甘油三酯治疗婴儿痉挛的方法 - Google Patents

用于使用中链甘油三酯治疗婴儿痉挛的方法 Download PDF

Info

Publication number
CN115884766A
CN115884766A CN202180038956.9A CN202180038956A CN115884766A CN 115884766 A CN115884766 A CN 115884766A CN 202180038956 A CN202180038956 A CN 202180038956A CN 115884766 A CN115884766 A CN 115884766A
Authority
CN
China
Prior art keywords
composition
infantile spasms
day
administered
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180038956.9A
Other languages
English (en)
Chinese (zh)
Inventor
J·瓦尔科
S·T·汉德森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rising Co
Original Assignee
Rising Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rising Co filed Critical Rising Co
Publication of CN115884766A publication Critical patent/CN115884766A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202180038956.9A 2020-05-29 2021-05-28 用于使用中链甘油三酯治疗婴儿痉挛的方法 Pending CN115884766A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063032111P 2020-05-29 2020-05-29
US63/032,111 2020-05-29
US202163176747P 2021-04-19 2021-04-19
US63/176,747 2021-04-19
PCT/US2021/034883 WO2021243226A1 (en) 2020-05-29 2021-05-28 Methods for the treatment of infantile spasms using medium chain triglycerides

Publications (1)

Publication Number Publication Date
CN115884766A true CN115884766A (zh) 2023-03-31

Family

ID=78744111

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180038956.9A Pending CN115884766A (zh) 2020-05-29 2021-05-28 用于使用中链甘油三酯治疗婴儿痉挛的方法

Country Status (8)

Country Link
US (1) US20230181512A1 (https=)
EP (1) EP4157250A4 (https=)
JP (1) JP2023527454A (https=)
KR (1) KR20230018462A (https=)
CN (1) CN115884766A (https=)
AU (1) AU2021281426A1 (https=)
CA (1) CA3184353A1 (https=)
WO (1) WO2021243226A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3595638A4 (en) * 2017-03-15 2020-09-16 Cerecin Inc. PHARMACEUTICAL COMPOSITIONS WITH HIGH DRUG LOADS BASED ON MEDIUM-CHAIN TRIGLYCERIDES AND RELATED METHODS

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649839A (zh) * 2002-04-30 2005-08-03 三得利株式会社 虾青素中链脂肪酸酯、其制造方法、以及含有其的组合物
CN1972697A (zh) * 2004-06-17 2007-05-30 威斯康星校友研究基地 治疗发作和发作性疾病的化合物和方法
US20140057885A1 (en) * 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US20150342902A1 (en) * 2014-05-29 2015-12-03 Insys Pharma, Inc. Stable cannabinoid formulations
WO2017204986A1 (en) * 2016-05-27 2017-11-30 Insys Development Company, Inc. Stable cannabinoid formulations
US20190091178A1 (en) * 2017-09-26 2019-03-28 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
US20190255003A1 (en) * 2016-10-24 2019-08-22 University Of South Florida Delaying latency to seizure by combinations of ketone supplements

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2986268C (en) * 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
EP3481387A4 (en) * 2016-08-11 2020-04-08 Ovid Therapeutics Inc METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES
CN110678173B (zh) * 2017-04-10 2023-03-28 维塔弗洛国际有限公司 用于治疗癫痫的组合物

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649839A (zh) * 2002-04-30 2005-08-03 三得利株式会社 虾青素中链脂肪酸酯、其制造方法、以及含有其的组合物
CN1972697A (zh) * 2004-06-17 2007-05-30 威斯康星校友研究基地 治疗发作和发作性疾病的化合物和方法
US20140057885A1 (en) * 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
CN104736159A (zh) * 2012-08-21 2015-06-24 萨奇治疗股份有限公司 治疗癫痫或癫痫持续状态的方法
US20150342902A1 (en) * 2014-05-29 2015-12-03 Insys Pharma, Inc. Stable cannabinoid formulations
WO2017204986A1 (en) * 2016-05-27 2017-11-30 Insys Development Company, Inc. Stable cannabinoid formulations
US20190255003A1 (en) * 2016-10-24 2019-08-22 University Of South Florida Delaying latency to seizure by combinations of ketone supplements
US20190091178A1 (en) * 2017-09-26 2019-03-28 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ADAM L. NUMIS等: "The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms", EPILEPSY RESEARCH, 22 June 2011 (2011-06-22), pages 172 *

Also Published As

Publication number Publication date
US20230181512A1 (en) 2023-06-15
CA3184353A1 (en) 2021-12-02
AU2021281426A1 (en) 2023-02-02
WO2021243226A1 (en) 2021-12-02
EP4157250A1 (en) 2023-04-05
JP2023527454A (ja) 2023-06-28
EP4157250A4 (en) 2024-06-19
KR20230018462A (ko) 2023-02-07

Similar Documents

Publication Publication Date Title
US8748400B2 (en) Use of ketogenic compounds for treatment of age-associated memory impairment
US10111849B2 (en) Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US20070179197A1 (en) Compositions and methods for improving or preserving brain function
US20070135376A1 (en) Method to reduce oxidative damage and improve mitochondrial efficiency
JP2016535036A (ja) 消化不良の処置における使用のためのモノアシルグリセロール及び脂溶性栄養素
KR101734152B1 (ko) 신경계 장애의 치료를 위한 아세토아세테이트의 모노글리세리드 및 유도체
EP1605950A2 (en) Novel chemical entities and methods for their use in treatment of metabolic disorders
EP4514332A1 (en) Administration of r-beta-hydroxybutyrate and related compounds in veterinary applications
CN115884766A (zh) 用于使用中链甘油三酯治疗婴儿痉挛的方法
JP2016535037A (ja) 非機械的基礎を有する吸収不良の処置における使用のためのモノアシルグリセロール及び脂溶性栄養素
CN121646465A (zh) 用于预防和/或治疗过氧化物酶体障碍的癸酸及其组合物
WO2023022984A1 (en) Methods for the treatment of migraine and related headache symptoms using tricaprylin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination